| __timestamp | Amneal Pharmaceuticals, Inc. | Ascendis Pharma A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 6274000 |
| Thursday, January 1, 2015 | 109679000 | 9415000 |
| Friday, January 1, 2016 | 118757000 | 11504000 |
| Sunday, January 1, 2017 | 109046000 | 13482000 |
| Monday, January 1, 2018 | 230435000 | 25057000 |
| Tuesday, January 1, 2019 | 289598000 | 48473000 |
| Wednesday, January 1, 2020 | 326727000 | 76669000 |
| Friday, January 1, 2021 | 365504000 | 160180000 |
| Saturday, January 1, 2022 | 399700000 | 221227000 |
| Sunday, January 1, 2023 | 429675000 | 264410000 |
| Monday, January 1, 2024 | 284545000 |
Cracking the code
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Ascendis Pharma A/S and Amneal Pharmaceuticals, Inc. have taken different paths in this regard over the past decade. From 2014 to 2023, Amneal Pharmaceuticals saw a staggering 408% increase in SG&A expenses, peaking at $429 million in 2023. In contrast, Ascendis Pharma's SG&A costs rose by 4,110%, reaching $264 million in the same year.
While both companies have seen significant growth in their SG&A expenses, Ascendis Pharma's rapid increase suggests aggressive expansion strategies. Meanwhile, Amneal's more gradual rise indicates a steady scaling of operations. Understanding these trends provides valuable insights into each company's strategic priorities and operational efficiencies. As the pharmaceutical landscape evolves, monitoring these expenses will be key to assessing future financial health.
Biogen Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Viatris Inc. and Ascendis Pharma A/S
Who Optimizes SG&A Costs Better? Insmed Incorporated or Amneal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ascendis Pharma A/S
Breaking Down SG&A Expenses: Ascendis Pharma A/S vs Blueprint Medicines Corporation
Breaking Down SG&A Expenses: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.